MicroPort CardioFlow Medtech Corporation (HKG:2160)
Hong Kong · Delayed Price · Currency is HKD 1.040
-0.030 (-2.80%)
Jan 21, 2026, 3:04 PM HKT
HKG:2160 Market Cap
HKG:2160 has a market cap or net worth of 6.81 billion as of January 20, 2026. Its market cap has increased by 309.22% in one year.
Market Cap
6.81B
Enterprise Value
5.71B
Revenue
402.73M
Ranking
n/a
PE Ratio
1,281.28
Stock Price
1.04
Market Cap Chart
Since February 4, 2021, HKG:2160's market cap has decreased from 44.53B to 6.81B, a decrease of -84.70%. That is a compound annual growth rate of -31.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 6.81B | -11.57% |
| Dec 31, 2025 | 7.70B | 369.57% |
| Dec 31, 2024 | 1.64B | -58.02% |
| Dec 29, 2023 | 3.91B | -37.80% |
| Dec 30, 2022 | 6.28B | -32.45% |
| Dec 31, 2021 | 9.30B | -79.11% |
| Feb 4, 2021 | 44.53B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 291.88B |
| Hansoh Pharmaceutical Group Company | 260.32B |
| JD Health International | 215.66B |
| WuXi Biologics | 164.43B |
| Innovent Biologics | 155.25B |
| Sino Biopharmaceutical | 124.24B |
| CSPC Pharmaceutical Group | 112.39B |
| Akeso | 111.46B |